Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2016, Article ID 8419719, 6 pages
http://dx.doi.org/10.1155/2016/8419719
Research Article

Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998–2011

1Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
2Department of Biostatistics, University of Iowa, Iowa City, IA 52242, USA
3Department of Pharmacy Practice and Science, University of Iowa, Iowa City, IA 52242, USA

Received 10 November 2015; Accepted 21 March 2016

Academic Editor: Suresh C. Tiwari

Copyright © 2016 Manish Suneja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. de Carvalho, C. de Andrade Regis, J. R. Kalil et al., “Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality,” Annals of Hepatology, vol. 11, no. 1, pp. 90–95, 2012. View at Google Scholar · View at Scopus
  2. V. Arroyo, P. Ginès, A. L. Gerbes et al., “Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis,” Hepatology, vol. 23, no. 1, pp. 164–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Batalier, P. Sort, P. Gines, and V. Arroyo, “Hepatorenal syndrome: definition, pathophysiology, clinical features and management,” Kidney International, Supplement, vol. 53, no. 66, pp. S47–S53, 1998. View at Google Scholar · View at Scopus
  4. F. Salerno, A. Gerbes, P. Ginès, F. Wong, and V. Arroyo, “Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis,” Gut, vol. 56, no. 9, pp. 1310–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Ginès, M. Guevara, V. Arroyo, and J. Rodés, “Hepatorenal syndrome,” The Lancet, vol. 362, no. 9398, pp. 1819–1827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Fede, G. D'Amico, V. Arvaniti et al., “Renal failure and cirrhosis: a systematic review of mortality and prognosis,” Journal of Hepatology, vol. 56, no. 4, pp. 810–818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Alessandria, A. Ottobrelli, W. Debernardi-Venon et al., “Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study,” Journal of Hepatology, vol. 47, no. 4, pp. 499–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Sharma, A. Kumar, B. C. Shrama, and S. K. Sarin, “An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response,” The American Journal of Gastroenterology, vol. 103, no. 7, pp. 1689–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Neri, D. Pulvirenti, M. Malaguarnera et al., “Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome,” Digestive Diseases and Sciences, vol. 53, no. 3, pp. 830–835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Sanyal, T. Boyer, G. Garcia-Tsao et al., “A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome,” Gastroenterology, vol. 134, no. 5, pp. 1360–1368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Martín-Llahí, M.-N. Pépin, M. Guevara et al., “Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study,” Gastroenterology, vol. 134, no. 5, pp. 1352–1359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Brinch, S. Møller, F. Bendtsen, U. Becker, and J. H. Henriksen, “Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease,” Journal of Hepatology, vol. 39, no. 1, pp. 24–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Fernández, M. Navasa, J. C. Garcia-Pagan et al., “Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis,” Journal of Hepatology, vol. 41, no. 3, pp. 384–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Fabrizi, A. Aghemo, and P. Messa, “Hepatorenal syndrome and novel advances in its management,” Kidney and Blood Pressure Research, vol. 37, no. 6, pp. 588–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Polverejan, J. C. Gardiner, C. J. Bradley, M. Holmes-Rovner, and D. Rovner, “Estimating mean hospital cost as a function of length of stay and patient characteristics,” Health Economics, vol. 12, no. 11, pp. 935–947, 2003. View at Publisher · View at Google Scholar · View at Scopus